Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Muscle-invasive urothelial carcinoma"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 17, Pp 2237-2248 (2023)
Kristen King-Concialdi,1 Kathleen Beusterien,1 Steven S Senglaub,1 Oliver Will,1 Dena H Jaffe,1 Miraj Y Patel,2 Michael R Harrison3 1Real-World Evidence, Cerner Enviza, an Oracle Company, North Kansas City, MO, USA; 2Health Economics and Outcomes Res
Externí odkaz:
https://doaj.org/article/a81ca4184b2e461ca5e501bf54827b48
Autor:
Mohamed Yousef Ali, Ahmed Yousef Aboelsaad, Ahmed M. Abdel Gawad, Tamer A. Abouelgreed, Ahmed A. El Gammal, Osama M. Ghoneimy, Eman M. El-Dydamony, Ahmed A Alrefaey, Eslam Mohamed, Sherif Azzam, Ayman Abdulmohaymen, Yasien Mohammed, Mohammed S. Abdelwahed, Ahmed Fawzi A. Elsayed, Basem A. Fathi, Nosaiba M. Abd Alrahim, Abeer S. Farag, Alaa R. Mahmoud, Hasan Ismail Mohamed, Seth Horsu, Abdulkarim Hasan
Publikováno v:
Archivio Italiano di Urologia e Andrologia (2023)
Background: Transurethral resection (TUR) followed by adjuvant therapy is still the treatment of choice of Non-Muscle-Invasive Bladder Urothelial Carcinoma (NMIBUC). However, recurrence is one of the most troublesome features of these lesions. Early
Externí odkaz:
https://doaj.org/article/2f522599a7aa426591a9b704a060af56
Autor:
Saba Yasir, Gustavo Fernandez-Castro, Numra Aslam Bajwa, Norman Block, Andrew Schally, Richard Cote, Merce Jorda
Publikováno v:
Surgical and Experimental Pathology, Vol 3, Iss 1, Pp 1-6 (2020)
Abstract Background Recurrent disease following failed chemotherapy for muscle-invasive urothelial carcinoma (UC) has no universally accepted treatment guidelines. Receptors for luteinizing hormone-releasing hormone (LHRHR) have recently been identif
Externí odkaz:
https://doaj.org/article/15baaa80500c43bc99035b85daae98db
Publikováno v:
Polish Journal of Pathology, Vol 69, Iss 3, Pp 234-242 (2018)
Androgen receptor (AR) activation plays an important role in the promotion and progression of urothelial tumorigenesis. Also, dysregulation of the Wnt/β-catenin signaling pathway has also been linked to bladder cancer growth. However, cross talk bet
Externí odkaz:
https://doaj.org/article/1f90f12ce6be4c06bcc061bdbc58e168
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sumanta K Pal, Diederik M Somford, Petros Grivas, Srikala S Sridhar, Shilpa Gupta, Joaquim Bellmunt, Guru Sonpavde, Mark T Fleming, Seth P Lerner, Yohann Loriot, Jean Hoffman-Censits, Begoña P Valderrama, Corina Andresen, Marco J Schnabel, Suzanne Cole, Siamak Daneshmand
Publikováno v:
Future Oncology. 18:2599-2614
PROOF 302 is an ongoing randomized, double-blind, placebo-controlled, adjuvant phase III trial (NCT04197986) in approximately 218 patients from 120 centers worldwide. Eligibility criteria include post-surgical high-risk muscle-invasive upper tract ur
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Indian Journal of Pathology and Microbiology, Vol 61, Iss 4, Pp 526-531 (2018)
Background: Transurethral resection of tumor is the main treatment of non-muscle-invasive urothelial carcinoma, but it is associated with high rate of recurrence and/or progression and this arouses the need for adjuvant therapy. Topoisomerase II (Top
Externí odkaz:
https://doaj.org/article/acc69d6752704281a3e7f1220f369bdb
Publikováno v:
Case Reports in Oncology, Vol 7, Iss 2, Pp 509-512 (2014)
Cutaneous metastatic implantation of non-muscle-invasive urothelial carcinoma via urine is a rare finding, and only few cases have been reported in the literature. Here, we present a case of metastatic urothelial carcinoma of the prepuce and glans pe
Externí odkaz:
https://doaj.org/article/be09775b35aa4c838f2a795d3ebe3e0d